Registration Dossier

Diss Factsheets

Administrative data

sub-chronic toxicity: inhalation
Type of information:
read-across based on grouping of substances (category approach)
Adequacy of study:
weight of evidence
Justification for type of information:
No data are available for the target substance. 90-day repeated dose oral toxicity studies are available for individual (o-, m- and p-) cresol isomers and all report NOAEL and LOAEL values of 50 and 150 mg/kg bw/d, respectively. Critical findings in the study with o-cresol included central nervous system depression and reductions in body weight and body weight gain. Critical findings in the study with m-cresol included reductions in body weight and body weight gain. Critical findings in the study with p-cresol include increased mortality, clinical signs (including lethargy, excessive salivation, tremor, occasional convulsions and coma), hepatotoxicity and nephrotoxicity. The data therefore demonstrate a higher degree of toxicity for p-cresol, which has a metabolic basis (see discussion above). OECD 422 screening studies available for xylenol (mixed isomers) and ethylphenol (mixed isomers) both report NOAEL values of 100 mg/kg bw/d. The xylenol study reports clinical signs (stained fur) and increased relative weights of the kidneys, liver and ovaries at the NOAEL of 245 mg/kg bw/d. The ethylphenol study reports clinical signs (stained fur, salivation) and increased relative weights of the kidneys, liver and ovaries at the NOAEL of 245 mg/kg bw/d. Read-across is therefore proposed to the study with xylenol as the closest structural analogue among the Category members.

Data source

Materials and methods

Principles of method if other than guideline:
Method: other
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Reaction mass of 2,4-xylenol and 2,5-xylenol
EC Number:
Cas Number:
Molecular formula:
Reaction mass of 2,4-xylenol and 2,5-xylenol
Test material form:
solid: bulk

Test animals

not specified
Details on test animals or test system and environmental conditions:
migrated dataset

Administration / exposure

Route of administration:
Type of inhalation exposure:
other: migrated dataset
other: migrated dataset
Remarks on MMAD:
MMAD / GSD: migrated dataset
Details on inhalation exposure:
migrated dataset
Details on analytical verification of doses or concentrations:
migrated dataset
Duration of treatment / exposure:
4 months
Frequency of treatment:
Doses / concentrations
Doses / Concentrations:0.01 mg/lBasis:
No. of animals per sex per dose:
migrated dataset
Control animals:
other: no data specified
Details on study design:
Post-exposure period: 2 months
Positive control:
migrated dataset


Observations and examinations performed and frequency:
migrated dataset
Sacrifice and pathology:
migrated dataset
Other examinations:
migrated dataset
migrated dataset

Results and discussion

Results of examinations

Details on results:
migrated dataset

Effect levels

Dose descriptor:
Effect level:
0.01 other: mg/l
Basis for effect level:
body weight and weight gain
clinical signs
dermal irritation
organ weights and organ / body weight ratios

Target system / organ toxicity

Critical effects observed:
not specified

Any other information on results incl. tables

Clinical signs of toxicity included loss of appetite, marked emaciation and decreased locomotor activity. Irritative effects, which persisted throughout recovery, were seen on
the nose, eye and skin.  Decreased body weight gain and lung weight, increased liver weight, oliguria and dystrophic changes in the lung and liver occurred. 

Throughout recovery the body weights remained depressed and urinary excretion remained low.

Applicant's summary and conclusion

Executive summary:

The above results are suitable to be used for read across for Reaction mass of 2,4-xylenol and 2,5-xylenol, due to the category being based on structural similarity and comparable physicochemical properties, leading to similar (eco)toxicological properties.